NP92520b Aflibercept (Eylea®)
A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 3.5 year
- Value
- £55M-£164M
- Sector
- HEALTH
- Published
- 18 Dec 2023
- Delivery
- To 18 Aug 2027 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Bayer Reading
Description
The Framework Agreement is for the supply of Aflibercept (Eylea®) solution for injection vials to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement. The Framework Participant is required to supply Goods to designated delivery points throughout Scotland for use by Participating Authorities.
Ammendments to Previous Notice
2. Contract value
GBP 109,422,991 164,134,486
Award Detail
| 1 | Bayer (Reading)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract modified due to unforeseen circumstances.
Legal Justification
This modification is necessary to meet the additional demands of the Scottish Health and Social Care sector to maintain necessary supply due to circumstances unforeseen by the Authority, during the Covid-19 pandemic and associated recovery to maintain necessary supply and remove unnecessary disruption from the Authority, and at this time have rendered this modification necessary, in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value of the Framework Agreement referred to in Section V.2.4 cover(s) the 20 month contract duration and the 24 month extension period of the Framework Agreement. (SC Ref:752190)
Reference
- FTS 037072-2023